Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binbin Cheng

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
European Journal of Medicinal Chemistry|December 9, 2024
Small molecule inhibitors targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for cancer immunotherapy (2020-2024)Binbin Cheng, Jinke Lv, Yao Xiao, et al.
Molecular Medicine Reports|July 25, 2020
Levistilide A reverses rat hepatic fibrosis by suppressing angiotensin II‑induced hepatic stellate cells activationShu Li, Wei Zhao, Zhimin Zhao, et al.
Journal of Medicinal Chemistry|June 26, 2025
Research Progress in Targeting GSPT1: Molecular Glues, Bifunctional Degraders, and Antibody-Enabled Molecular Glues for Cancer TherapyBinbin Cheng, Yaping Wang, Yimeng Hong, et al.
European Journal of Medicinal Chemistry|February 7, 2025
Research progress in bifunctional small molecules for cancer immunotherapyBinbin Cheng, Hongqiao Li, Yimeng Hong, et al.
Journal of Medicinal Chemistry|April 25, 2024
Recent Progress in DNA Damage Response-Targeting PROTAC DegradersBinbin Cheng, Xiaoting Fei, Zongbao Ding, et al.
Asian Journal of Pharmaceutical Sciences|March 11, 2026
Advances in molecular glue degraders for targeted protein degradation: Focus on NEK7, WEE1, CDK2, GSPT1 and VAV1Binbin Cheng, Yaping Wang, Yimeng Hong, et al.
European Journal of Medicinal Chemistry|December 7, 2020
Discovery of novel CA-4 analogs as dual inhibitors of tubulin polymerization and PD-1/PD-L1 interaction for cancer treatmentXuchao Yang, Binbin Cheng, Yao Xiao, et al.
Bioorganic & Medicinal Chemistry|August 29, 2021
Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activitiesYichang Ren, Yong Ruan, Binbin Cheng, et al.
Journal of Medicinal Chemistry|November 7, 2024
Small-Molecule Modulators Targeting Coactivator-Associated Arginine Methyltransferase 1 (CARM1) as Therapeutic Agents for Cancer Treatment: Current Medicinal Chemistry Insights and Emerging OpportunitiesShuqing Li, Wanyi Pan, Chengpeng Tao, et al.
Journal of Medicinal Chemistry|July 21, 2023
Discovery of Novel d-(+)-Biotin-Conjugated Resorcinol Dibenzyl Ether-Based PD-L1 Inhibitors for Targeted Cancer ImmunotherapyZongbao Ding, Shuanghu Wang, Yaru Shi, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
European Journal of Medicinal Chemistry|December 9, 2024
Small molecule inhibitors targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for cancer immunotherapy (2020-2024)Binbin Cheng, Jinke Lv, Yao Xiao, et al.
Molecular Medicine Reports|July 25, 2020
Levistilide A reverses rat hepatic fibrosis by suppressing angiotensin II‑induced hepatic stellate cells activationShu Li, Wei Zhao, Zhimin Zhao, et al.
Journal of Medicinal Chemistry|June 26, 2025
Research Progress in Targeting GSPT1: Molecular Glues, Bifunctional Degraders, and Antibody-Enabled Molecular Glues for Cancer TherapyBinbin Cheng, Yaping Wang, Yimeng Hong, et al.
European Journal of Medicinal Chemistry|February 7, 2025
Research progress in bifunctional small molecules for cancer immunotherapyBinbin Cheng, Hongqiao Li, Yimeng Hong, et al.
Journal of Medicinal Chemistry|April 25, 2024
Recent Progress in DNA Damage Response-Targeting PROTAC DegradersBinbin Cheng, Xiaoting Fei, Zongbao Ding, et al.
Asian Journal of Pharmaceutical Sciences|March 11, 2026
Advances in molecular glue degraders for targeted protein degradation: Focus on NEK7, WEE1, CDK2, GSPT1 and VAV1Binbin Cheng, Yaping Wang, Yimeng Hong, et al.
European Journal of Medicinal Chemistry|December 7, 2020
Discovery of novel CA-4 analogs as dual inhibitors of tubulin polymerization and PD-1/PD-L1 interaction for cancer treatmentXuchao Yang, Binbin Cheng, Yao Xiao, et al.
Bioorganic & Medicinal Chemistry|August 29, 2021
Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activitiesYichang Ren, Yong Ruan, Binbin Cheng, et al.
Journal of Medicinal Chemistry|November 7, 2024
Small-Molecule Modulators Targeting Coactivator-Associated Arginine Methyltransferase 1 (CARM1) as Therapeutic Agents for Cancer Treatment: Current Medicinal Chemistry Insights and Emerging OpportunitiesShuqing Li, Wanyi Pan, Chengpeng Tao, et al.
Journal of Medicinal Chemistry|July 21, 2023
Discovery of Novel d-(+)-Biotin-Conjugated Resorcinol Dibenzyl Ether-Based PD-L1 Inhibitors for Targeted Cancer ImmunotherapyZongbao Ding, Shuanghu Wang, Yaru Shi, et al.
Pageof 10